Cancer propensities in Mxd2−/− mice may thus reflect both a greater abundance of Myc protein, more efficient Myc binding to its target genes, increases in the expression of target genes that normally bind Myc with low affinity and a loss of repression of key Mxd2 targets. The gene discussed is MYC; the disease is cancer.